“CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY” (2025) International journal of medical sciences, 5(05), pp. 396–403. doi:10.55640/.